Search for: "Ortho-McNeil Pharmaceutical"
Results 241 - 260
of 270
Sorted by Relevance
|
Sort by Date
17 Feb 2012, 11:29 am
Ortho-McNeil-Janssen Pharmaceuticals Inc., 2010 WL 3548474 (Pa. [read post]
19 Sep 2011, 8:41 am
Ortho McNeil Pharmaceutical is in accord with the law of most states in the country. [read post]
28 Jun 2010, 3:50 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2181 (Phila. [read post]
31 Dec 2014, 5:00 am
Ortho-McNeil-Janssen Pharmaceutical, Inc. v. [read post]
28 Jun 2007, 10:16 am
Although it is doubtful that the Prohias litigation will ever get anywhere near class certification, these plaintiffs' conduct demonstrates the individualized nature of the inquiry, even in stripped-down consumer fraud litigation.From our perspective Prohias II, gets into even jucier defenses, since it's more specific to the pharmaceutical industry. [read post]
2 Mar 2012, 6:52 am
Ortho-McNeil (?) [read post]
9 Aug 2012, 5:00 am
Ortho-McNeil (?) [read post]
1 Mar 2007, 4:57 am
The third generation oral contraceptives containing desogestrel are:Desogestrel and Ethinyl Estradiol (Duramed/Barr and Watson Pharmaceuticals)Desogen (Organon)Mircette (Duramed/Barr)Velivet (Duramed)Apri-28 (Duramed/Barr)Kariva (Duramed/Barr)Ortho-Cept (Ortho-McNeil)Reclipsen (Watson)Cyclessa (Organon)It is estimated that women in the U.S. filled more than 7.5 million prescriptions for third generation oral contraceptives this past year (November 2005 to October… [read post]
16 May 2013, 2:09 pm
Ortho-McNeil-Janssen Pharmaceuticals, 2013 Phila. [read post]
4 Mar 2012, 9:02 am
Merrill Dow Pharmaceuticals, Inc., 874 F.2d 307, 311-12 (5th Cir. 1989)(“Fortunately, we do not have to resolve any of the above questions [as to bias and confounding], since the studies presented to us incorporate the possibility of these factors by the use of a confidence interval. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
19 Sep 2013, 9:53 am
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]
11 Jul 2008, 4:30 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
6 Aug 2009, 11:24 pm
" Ortho-McNeil Pharm., Inc. v. [read post]
25 Jan 2007, 12:48 am
Ortho Pharmaceutical Corp., 661 N.E.2d 352, 355-56 (Ill. 1996). [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
29 Aug 2008, 1:25 pm
: (IP finance), Facebook removes international access to Scrabulous, except from India: (Ars Technica), (Techdirt), Reverse engineering can resolve conflict between standardisation and competition: (Techdirt), Benefits of piracy aren’t always in the expected places: (Techdirt) Events 1-3 September: Federation of Indian Chambers of Commerce and Industry, Department of Industrial Property and Promotion, and WIPO conference on ‘Development and IP: Building synergies… [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) – Lundbeck wins… [read post]
3 Sep 2015, 6:36 am
“Jurisfiction” is a word coined by Jasper Fforde, author of the Tuesday Next series, one of the more sophisticated set of children’s works that has come to populate this post-Harry Potter era. [read post]
27 Jul 2012, 12:40 pm
“[A]s condemnable as [the] flouting of FDA regulations may be, the off-label promotion of a pharmaceutical product in violation of the FDCA simply does not give rise to fraud-based rights of action. [read post]
